DMC1
Description
What is DMC1?
DMC1 (Deleted in Myelodysplastic Syndromes 1) is a gene that provides instructions for making a protein called ubiquitin ligase E3 component n-recognin 2 (UBR2). UBR2 plays a crucial role in regulating protein degradation, a process essential for maintaining cellular homeostasis.
Mutations in the DMC1 gene lead to a defective UBR2 protein, which impairs its ability to properly target and degrade specific proteins. This disruption can result in a buildup of abnormal proteins, causing cellular dysfunction and ultimately leading to the development of cancer.
Associated Diseases
DMC1 mutations have been primarily linked to myelodysplastic syndromes (MDS), a group of blood disorders characterized by abnormal cell growth and function in the bone marrow. MDS can progress to acute myeloid leukemia (AML), a more aggressive form of blood cancer.
DMC1 mutations are also implicated in other types of hematologic malignancies, including:
- Chronic lymphocytic leukemia (CLL)
- Acute lymphoblastic leukemia (ALL)
- Myelofibrosis
Did you Know ?
Approximately 15-20% of patients with MDS have mutations in the DMC1 gene. This makes DMC1 mutations one of the most common genetic alterations in MDS.
